Emodin Reverses the Epithelial–Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway

References

• ZondervanKT, BeckerCM, MissmerSA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256.32212520
   PubMed Web of Science ®Google Scholar
• PeirisAN, ChaljubE, MedlockD. Endometriosis. JAMA. 2018;320(24):2608.30575883
   PubMedGoogle Scholar
• BozdagG. Recurrence of endometriosis: risk factors, mechanisms and biomarkers. Women’s Health. 2015;11(5):693–699.
   PubMedGoogle Scholar
• VinatierD, OraziG, CossonM, DufourP. Theories of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2001;96(1):21–34.11311757
   PubMed Web of Science ®Google Scholar
• XiongW, ZhangL, ELH. -mediated EMT by activation of beta-catenin/Snail signalling during the development of ovarian endometriosis. J Cell Mol Med. 2019;23(12):8035–8045.31560827
   PubMed Web of Science ®Google Scholar
• YangYM, YangWX. Epithelial-to-mesenchymal transition in the development of endometriosis. Oncotarget. 2017;8(25):41679–41689.28415639
   PubMedGoogle Scholar
• WangS, ZhangM, ZhangT, DengJ, XiaX, FangX. microRNA-141 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition through inhibition of the TGF-beta1/SMAD2 signalling pathway in endometriosis. Arch Gynecol Obstet. 2020;301(3):707–714.31903498
   PubMed Web of Science ®Google Scholar
• ZhengQM, LuJJ, ZhaoJ, WeiX, WangL, LiuPS. Periostin facilitates the epithelial-mesenchymal transition of endometrial epithelial cells through ILK-Akt signaling pathway. Biomed Res Int. 2016;2016:9842619.27034956
   PubMed Web of Science ®Google Scholar
• ZhengQM, ChenXY, BaoQF, YuJ, ChenLH. ILK enhances migration and invasion abilities of human endometrial stromal cells by facilitating the epithelial-mesenchymal transition. Gynecol Endocrinol. 2018;34(12):1091–1096.30182767
   PubMed Web of Science ®Google Scholar
• ZhengCC, HuHF, HongP, et al. Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer. Am J Cancer Res. 2019;9(1):186–197.30755822
   PubMed Web of Science ®Google Scholar
• TsoumasD, NikouS, GiannopoulouE, et al. ILK expression in colorectal cancer is associated with EMT, cancer stem cell markers and chemoresistance. Cancer Genomics Proteomics. 2018;15(2):127–141.29496692
   PubMed Web of Science ®Google Scholar
• ZhouW, PengZ, ZhangC, LiuS, ZhangY. ILK-induced epithelial-mesenchymal transition promotes the invasive phenotype in adenomyosis. Biochem Biophys Res Commun. 2018;497(4):950–956.29409901
   PubMed Web of Science ®Google Scholar
• ZhangY, HuangW. Transforming Growth Factor beta1 (TGF-beta1)-stimulated Integrin-Linked Kinase (ILK) regulates migration and epithelial-mesenchymal transition (EMT) of human lens epithelial cells via nuclear factor kappaB (NF-kappaB). Med Sci Monit. 2018;24:7424–7430.30332398
   PubMed Web of Science ®Google Scholar
• PangM, WangH, RaoP, et al. Autophagy links beta-catenin and Smad signaling to promote epithelial-mesenchymal transition via upregulation of integrin linked kinase. Int J Biochem Cell Biol. 2016;76:123–134.27177845
   PubMed Web of Science ®Google Scholar
• ShenH, MaJL, ZhangY, et al. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-kappaB signaling in colorectal cancer cells. World J Gastroenterol. 2016;22(15):3969–3977.27099440
   PubMed Web of Science ®Google Scholar
• GilD, Ciolczyk-WierzbickaD, Dulinska-LitewkaJ, LaidlerP. Integrin-linked kinase regulates cadherin switch in bladder cancer. Tumour Biol. 2016;37(11):15185–15191.27683053
   PubMedGoogle Scholar
• YangJ, HouY, ZhouM, et al. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network. Int J Biochem Cell Biol. 2016;71:62–71.26693891
   PubMed Web of Science ®Google Scholar
• NingZ, ZhuX, JiangY, et al. Integrin-linked kinase is involved in the proliferation and invasion of esophageal squamous cell carcinoma. J Cancer. 2020;11(2):324–333.31897228
   PubMed Web of Science ®Google Scholar
• LiangF, ZhangS, WangB, QiuJ, WangY. Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-kappaB pathway. J Mol Histol. 2014;45(2):141–151.24045896
   PubMed Web of Science ®Google Scholar
• DongX, FuJ, YinX, et al. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytother Res. 2016;30(8):1207–1218.27188216
   PubMed Web of Science ®Google Scholar
• WayTD, HuangJT, ChouCH, HuangCH, YangMH, HoCT. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the beta-catenin and Akt pathways. Eur J Cancer. 2014;50(2):366–378.24157255
   PubMed Web of Science ®Google Scholar
• ChenT, ZhengLY, XiaoW, GuiD, WangX, WangN. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo. Cell Physiol Biochem. 2015;35(4):1425–1436.25791065
   PubMedGoogle Scholar
• SongY, ShengZ, XuY, et al. Magnetic liposomal emodin composite with enhanced killing efficiency against breast cancer. Biomaterials sci. 2019;7(3):867–875.
   PubMed Web of Science ®Google Scholar
• ZhengXY, YangSM, ZhangR, WangSM, LiGB, ZhouSW. Emodin-induced autophagy against cell apoptosis through the PI3K/AKT/mTOR pathway in human hepatocytes. Drug Des Devel Ther. 2019;13:3171–3180.
   PubMed Web of Science ®Google Scholar
• ZhengQ, XuY, LuJ, ZhaoJ, WeiX, LiuP. Emodin inhibits migration and invasion of human endometrial stromal cells by facilitating the mesenchymal-epithelial transition through targeting ILK. Reprod Sci. 2016;23(11):1526–1535.27130230
   PubMed Web of Science ®Google Scholar
• DaiG, DingK, CaoQ, et al. Emodin suppresses growth and invasion of colorectal cancer cells by inhibiting VEGFR2. Eur J Pharmacol. 2019;859:172525.31288005
   PubMed Web of Science ®Google Scholar
• GuJ, CuiCF, YangL, WangL, JiangXH. Emodin inhibits colon cancer cell invasion and migration by suppressing epithelial-mesenchymal transition via the wnt/beta-catenin pathway. Oncol Res. 2019;27(2):193–202.29301594
   PubMed Web of Science ®Google Scholar
• LuJ, XuY, ZhaoZ, et al. Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo. Onco Targets Ther. 2017;10:3579–3589.28790850
   PubMed Web of Science ®Google Scholar
• WuPA, XieLL, ZhaoDY, et al. Integrin-linked kinase is overexpressed in laryngeal squamous cell carcinoma and correlates with tumor proliferation, migration and invasion. Eur Rev Med Pharmacol Sci. 2018;22(24):8740–8748.30575914
   PubMed Web of Science ®Google Scholar
• GilD, ZarzyckaM, Ciolczyk-WierzbickaD, LaidlerP. Integrin linked kinase regulates endosomal recycling of N-cadherin in melanoma cells. Cell Signal. 2020;72:109642.32305668
   PubMed Web of Science ®Google Scholar
• XingY, CuiL, KangQ. Silencing of ILK attenuates the abnormal proliferation and migration of human Tenon’s capsule fibroblasts induced by TGF-beta2. Int J Mol Med. 2016;38(2):407–416.27315599
   PubMed Web of Science ®Google Scholar
• LuoL, LiuH, DongZ, SunL, PengY, LiuF. Small interfering RNA targeting ILK inhibits EMT in human peritoneal mesothelial cells through phosphorylation of GSK3beta. Mol Med Rep. 2014;10(1):137–144.24756461
   PubMed Web of Science ®Google Scholar
• TangQ, ZhaoS, WuJ, et al. Inhibition of integrin-linked kinase expression by emodin through crosstalk of AMPKalpha and ERK1/2 signaling and reciprocal interplay of Sp1 and c-Jun. Cell Signal. 2015;27(7):1469–1477.25889897
   PubMed Web of Science ®Google Scholar
• XuX, ZhengQ, ZhangZ, ZhangX, LiuR, LiuP. Periostin enhances migration, invasion, and adhesion of human endometrial stromal cells through integrin-linked kinase 1/Akt signaling pathway. Reprod Sci. 2015;22(9):1098–1106.25759370
   PubMed Web of Science ®Google Scholar
• QueL, ZhaoD, TangXF, et al. Effects of lentivirus-mediated shRNA targeting integrin-linked kinase on oral squamous cell carcinoma in vitro and in vivo. Oncol Rep. 2016;35(1):89–98.26531674
   PubMed Web of Science ®Google Scholar
• YanZ, YinH, WangR, et al. Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via NF-kappaB signaling. Acta Histochem. 2014;116(3):527–533.24360977
   PubMed Web of Science ®Google Scholar
• ParkSJ, JinML, AnHK, et al. Emodin induces neurite outgrowth through PI3K/Akt/GSK-3beta-mediated signaling pathways in Neuro2a cells. Neurosci Lett. 2015;588:101–107.25562207
   PubMed Web of Science ®Google Scholar
• LiuZC, ChenXH, SongHX, et al. Snail regulated by PKC/GSK-3beta pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells. Cell Tissue Res. 2014;358(2):491–502.25124796
   PubMed Web of Science ®Google Scholar
• DobleBW, PatelS, WoodGA, KockeritzLK, WoodgettJR. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell. 2007;12(6):957–971.17543867
   PubMed Web of Science ®Google Scholar
• ZhouBP, DengJ, XiaW, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004;6(10):931–940.15448698
   PubMed Web of Science ®Google Scholar
• WuZQ, LiXY, HuCY, FordM, KleerCG, WeissSJ. Canonical Wnt signaling regulates slug activity and links epithelial-mesenchymal transition with epigenetic breast cancer 1, early onset (BRCA1) repression. Proc Natl Acad Sci U S A. 2012;109(41):16654–16659.23011797
   PubMed Web of Science ®Google Scholar
• LuJ, XuY, WeiX, ZhaoZ, XueJ, LiuP. Emodin inhibits the epithelial to mesenchymal transition of epithelial ovarian cancer cells via ILK/GSK-3beta/slug signaling pathway. Biomed Res Int. 2016;2016:6253280.28097141
   PubMed Web of Science ®Google Scholar